logo

UK News

Share

bankofengland-june21.jpg Bank of England's rate-setting body witnessed a growing divide at the June meeting, after its chief economist Andrew Haldane joined the hawks seeking an interest rate hike. Policymakers also set out new guidance on when to consider reducing the quantitative easing programme. Six members of the Monetary Policy Committee including Governor Mark Carney voted to maintain the benchmark rate.

sangamobuilding-june21.jpg Shares of Sangamo Therapeutics Inc. (SGMO) are down nearly 33% from their 52-week high to $18. Given the fact that the Company has potential clinical data readouts from 7 studies beginning in late summer of this year to 2019, it is worth keeping an eye on this stock.

asian-markets2_21jun18.jpg European stocks were subdued on Thursday as trade worries persisted and investors waited to see if OPEC and its allies would reach consensus on a deal to increase oil supply. The Bank of England will announce its interest-rate decision later today, with traders looking for any hints of an August rate...

asian-markets1_21jun18.jpg European stocks may open higher on Thursday despite the looming threat of a full-blown trade war between the world's two largest economies. In response to U.S. President Donald Trump's decision to impose tariffs on EU steel and aluminum early this morning, the European Union will start charging import...

pharma-042318.jpg Today's Daily Dose brings you news about Atossa's progress in phase I study of its proprietary topical Endoxifen in men; the three biopharmaceutical companies that are set to debut on the Nasdaq on June 21, 2018; Kindred Biosciences' financial position; FDA panel review date of Paratek's Omadacycline NDA, and STAAR Surgical's resolution of FDA warning letter.

pharma-june19.jpg The following are some of today's top gainers in the pharma/biotech sector.

stock-market-500_20jun18.jpg European stocks rebounded from three-week lows hit on Tuesday as investors took trade tensions in their stride and looked ahead to Bank of England and OPEC meetings for direction. While the Bank of England is unlikely to alter the status quo on rates on Thursday, the ministers of OPEC and non-OPEC...

asian-market-100912_20jun18.jpg European stocks look set to rebound from three-week lows hit the previous day, although a burgeoning trade war between the U.S. and China showed little signs of slowing down. Asian stocks recovered from early losses to trade mostly higher even as Chinese markets extended a rout from the previous...

pharma-daily-060618.jpg Today's Daily Dose brings you news about Alexion's progress in paroxysmal nocturnal hemoglobinuria; Anika's disappointing results of CINGAL in osteoarthritis of the knee; timeline of Kala's submission of New Drug Application for KPI-121 0.25% for the treatment of dry eye disease; Marinus' Marigold study and Pacira's deal with China-based Nuance Biotech.

pharma-daily-061218.jpg The following are some of today's top gainers in the pharma/biotech sector.

cryptos-june19.jpg Bitcoin and its peers managed to sustain the upward momentum they gained over the past few hours and are firmly in the green Tuesday morning. The cryptomarket capitalization recovered strongly on Monday and is at $293.41 billion around 9.15 am ET. Here is a wrap of the main news from the cryptocurrency and blockchain world over the past 24 hours.

stock-market-down_19jun18.jpg European stocks fell sharply on Tuesday to hover near two-month lows as a slew of profit warnings coupled with an escalating trade spat between the world's two biggest economies soured investors' appetite for risk. The pan-European Stoxx Europe 600 index was down 0.8 percent at 382.95 in late opening...

fda-june15.jpg The bench to bedside journey of drugs is no easy task. Some drug candidates fail to complete the journey while many make it to the finish line only after undergoing numerous obstacles.

markets-111714_19jun18.jpg European stocks look set to open lower on Tuesday as U.S. President Donald Trump threatened more tariffs on Chinese goods in an escalating tit-for-tat trade war between the world's two biggest economies. The dollar fell against the yen and Swiss franc and oil dipped on supply worries while gold inched...

pharma-june19.jpg Today's Daily Dose brings you news about Royalty Pharma's investment in Biohaven Pharma; Champions Oncology's partnership with NSABP Foundation and Puma Biotechnology; upcoming regulatory catalyst of Myriad Genetics; Valeant Pharma's plaque psoriasis setback; Sarepta's presentation to watch out for the day, and FDA hold on Ziopharm's phase I trial of CD19-targeted CAR T therapy.

Follow RTT